News

PulmoSIM Therapeutics Announces Strategic Partnership with Top Respiratory Hospitals to Initiate Clinical Development of PT001 to Treat Pulmonary Arterial Hypertension

All the sessions from Transform 2021 are available on-demand now. Watch now. After receiving orphan drug designation, PulmoSIM in partnership

Read more